Australian Clinical Labs Limited

ASX:ACL Stock Report

Mkt Cap: AU$610.5m

Australian Clinical Labs Future Growth

How is Australian Clinical Labs forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


-53.3%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

ASX:ACL - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202572147N/A1635
6/30/2024696441441536
6/30/2023714501461636
6/30/2022996178263284N/A
3/31/2022931156238256N/A
12/31/2021867134214228N/A
9/30/202175797179191N/A
6/30/202164760144154N/A
3/31/202159879N/AN/AN/A
12/31/202054998N/AN/AN/A
9/30/202052070N/AN/AN/A
6/30/20204914192102N/A
6/30/2019448-11-131N/A
6/30/2018379-9-45N/A
6/30/2017340-24-35N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ACL's earnings are forecast to decline over the next 3 years (-53.3% per year).

Earnings vs Market: ACL's earnings are forecast to decline over the next 3 years (-53.3% per year).

High Growth Earnings: ACL's earnings are forecast to decline over the next 3 years.

Revenue vs Market: ACL's revenue is expected to decline over the next 3 years (-6.6% per year).

High Growth Revenue: ACL's revenue is forecast to decline over the next 3 years (-6.6% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ACL's Return on Equity is forecast to be low in 3 years time (18.9%).


Discover growth companies